Catalyst
Slingshot members are tracking this event:
Five Prime Therapeutics (FPRX) to complete Phase 1 study of FPA144 in patients with Advanced Solid Tumors by early 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| FPRX |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 01, 2016
Occurred Source:
http://investor.fiveprime.com/releasedetail.cfm?ReleaseID=1001873
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Solid Tumors, Phase 1 Study, Fpa 144, Gastric Cancer
